Vasocard
Category
Vasocard Brand names, Vasocard Analogs
Vasocard Brand Names Mixture
Vasocard Chemical_Formula
C19H25N5O4
Vasocard RX_link
http://www.rxlist.com/cgi/generic/teraz.htm
Vasocard fda sheet
Vasocard msds (material safety sheet)
Vasocard Synthesis Reference
M. Winn et al., U.S. Pat. 4,026,894 (1977)
Vasocard Molecular Weight
387.433 g/mol
Vasocard Melting Point
273 oC
Vasocard H2O Solubility
29.7mg/mL
Vasocard State
Solid
Vasocard LogP
0.875
Vasocard Dosage Forms
Tablet
Vasocard Indication
For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.
Vasocard Pharmacology
Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.
Vasocard Absorption
Essentially completely absorbed in man (90% bioavailability).
Vasocard side effects and Toxicity
LD50=259.3mg/kg (i.v. in mice)
Vasocard Patient Information
Vasocard Organisms Affected
Humans and other mammals
